FDA Approves ‘First-in-Class’ NDSRI for ADHD in Adults and Children
SIMTRIYO is a newly approved central nervous system medication to help treat ADHD in children and adults. Image Credit: Tom Werner/DigitalVision via Getty Images Federal regulators have approved a new medication to help manage attention deficit hyperactivity disorder (ADHD). SIMT